美股市场个股详情
SNSE Sensei Biotherapeutics
- 1.020
- +0.020+1.99%
收盘价 04/26 16:00 (美东)
2557.24万总市值-836市盈率TTM
1.040最高价1.000最低价6161股成交量1.040今开1.000昨收6274.34成交额0.04%换手率亏损市盈率(静)2507.10万总股本1.72052周最高0.39市净率1673.87万流通值0.51052周最低--股息TTM1641.05万流通股26.500历史最高--股息率TTM4.00%振幅0.510历史最低1.018平均价1股每手
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Sensei Biotherapeutics股票讨论区
Biotherapeutics Company Announces Revolutionary Cancer Treatment Development
In the ongoing battle against cancer, groundbreaking research and innovative treatments are the beacons of hope for patients worldwide. One such beacon shines brightly from the laboratories of Sensei Biotherapeutics, Inc., a clinical-stage immuno-oncology company dedicated to the discovery and development of next-gen...
NEWS
Sensei Biotherapeutics, Inc. (SNSE) announces the publication of a research paper in Nature Communications detailing the development of SNS-101, a pH-sensitive monoclonal antibody targeting VISTA to suppress T-cell activation in cancer patients. The paper highlights the unique mechanism of SNS-101 in mitigating CRS risk and maintaining a favorable safety profile, potentially revolutionizing VISTA-directed immunotherapy.
Interesting News
👀
专栏US Top Rating Updates on 10/3: WFC, ADBE, MU, STX and More
• $Box Inc(BOX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $CF工业控股(CF.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $135 (from $110)
• $New Gold(NGD.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $1.25 (from $1)
• $Sensei Biotherapeutics(SNSE.US)$: Oppenheimer Upgrades to Outperform from Perform - PT $5
• $Senetas Corp Ltd(SEN.AU)$ : Tru...
暂无评论